title: The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis.
abstract: Predicting and understanding the mechanism of drug-induced toxicity is one of the primary goals of drug development. It has been hypothesized that inflammation may have a synergistic role in this process. Cell-based models provide an easily manipulated system to investigate this type of drug toxicity. Several groups have attempted to reproduce in vivo toxicity with combination treatment of pharmacological agents and inflammatory cytokines. Through this approach, synergistic cytotoxicity between the investigational agent pevonedistat (MLN4924) and TNF-α was identified. Pevonedistat is an inhibitor of the NEDD8-activating enzyme (NAE). Inhibition of NAE prevents activation of cullin-RING ligases, which are critical for proteasome-mediated protein degradation. TNF-α is a cytokine that is involved in inflammatory responses and cell death, among other biological functions. Treatment of cultured cells with the combination of pevonedistat and TNF-α, but not as single agents, resulted in rapid cell death. This cell death was determined to be mediated by caspase-8. Interestingly, the combination treatment of pevonedistat and TNF-α also caused an accumulation of the p10 protease subunit of caspase-8 that was not observed with cytotoxic doses of TNF-α. Under conditions where apoptosis was blocked, the mechanism of death switched to necroptosis. Trimerized MLKL was verified as a biomarker of necroptotic cell death. The synergistic toxicity of pevonedistat and elevated TNF-α was also demonstrated by in vivo rat studies. Only the combination treatment resulted in elevated serum markers of liver damage and single-cell hepatocyte necrosis. Taken together, the results of this work have characterized a novel synergistic toxicity driven by pevonedistat and TNF-α.
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: F S
authors.initials: FS
authors.lastname: Wolenski
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Fisher
authors.affiliation: Drug Safety Research Laboratories, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa , Kanagawa, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sano
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: S D
authors.initials: SD
authors.lastname: Wyllie
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Cicia
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Gallacher
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: R A
authors.initials: RA
authors.lastname: Baker
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Kirby
authors.affiliation: Drug Safety Research and Evaluation, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , 35 Landsdowne Street, Cambridge, MA, USA.
authors.forename: J J
authors.initials: JJ
authors.lastname: Senn